S&P 500   2,978.76 (-4.42%)
DOW   25,766.64 (-4.42%)
QQQ   205.64 (-5.01%)
AAPL   273.52 (-6.54%)
FB   189.75 (-3.78%)
MSFT   158.18 (-7.05%)
GOOGL   1,314.95 (-5.43%)
AMZN   1,884.30 (-4.81%)
CGC   18.44 (-6.96%)
NVDA   252.60 (-5.62%)
BABA   205.03 (-1.78%)
MU   50.58 (-3.42%)
GE   10.39 (-5.11%)
TSLA   679.00 (-12.81%)
AMD   44.01 (-7.33%)
T   35.73 (-3.69%)
ACB   1.45 (-3.97%)
F   6.97 (-3.33%)
NFLX   371.71 (-1.99%)
PRI   114.78 (-4.46%)
BAC   29.13 (-4.90%)
DIS   118.04 (-4.31%)
GILD   72.66 (-2.73%)
S&P 500   2,978.76 (-4.42%)
DOW   25,766.64 (-4.42%)
QQQ   205.64 (-5.01%)
AAPL   273.52 (-6.54%)
FB   189.75 (-3.78%)
MSFT   158.18 (-7.05%)
GOOGL   1,314.95 (-5.43%)
AMZN   1,884.30 (-4.81%)
CGC   18.44 (-6.96%)
NVDA   252.60 (-5.62%)
BABA   205.03 (-1.78%)
MU   50.58 (-3.42%)
GE   10.39 (-5.11%)
TSLA   679.00 (-12.81%)
AMD   44.01 (-7.33%)
T   35.73 (-3.69%)
ACB   1.45 (-3.97%)
F   6.97 (-3.33%)
NFLX   371.71 (-1.99%)
PRI   114.78 (-4.46%)
BAC   29.13 (-4.90%)
DIS   118.04 (-4.31%)
GILD   72.66 (-2.73%)
S&P 500   2,978.76 (-4.42%)
DOW   25,766.64 (-4.42%)
QQQ   205.64 (-5.01%)
AAPL   273.52 (-6.54%)
FB   189.75 (-3.78%)
MSFT   158.18 (-7.05%)
GOOGL   1,314.95 (-5.43%)
AMZN   1,884.30 (-4.81%)
CGC   18.44 (-6.96%)
NVDA   252.60 (-5.62%)
BABA   205.03 (-1.78%)
MU   50.58 (-3.42%)
GE   10.39 (-5.11%)
TSLA   679.00 (-12.81%)
AMD   44.01 (-7.33%)
T   35.73 (-3.69%)
ACB   1.45 (-3.97%)
F   6.97 (-3.33%)
NFLX   371.71 (-1.99%)
PRI   114.78 (-4.46%)
BAC   29.13 (-4.90%)
DIS   118.04 (-4.31%)
GILD   72.66 (-2.73%)
S&P 500   2,978.76 (-4.42%)
DOW   25,766.64 (-4.42%)
QQQ   205.64 (-5.01%)
AAPL   273.52 (-6.54%)
FB   189.75 (-3.78%)
MSFT   158.18 (-7.05%)
GOOGL   1,314.95 (-5.43%)
AMZN   1,884.30 (-4.81%)
CGC   18.44 (-6.96%)
NVDA   252.60 (-5.62%)
BABA   205.03 (-1.78%)
MU   50.58 (-3.42%)
GE   10.39 (-5.11%)
TSLA   679.00 (-12.81%)
AMD   44.01 (-7.33%)
T   35.73 (-3.69%)
ACB   1.45 (-3.97%)
F   6.97 (-3.33%)
NFLX   371.71 (-1.99%)
PRI   114.78 (-4.46%)
BAC   29.13 (-4.90%)
DIS   118.04 (-4.31%)
GILD   72.66 (-2.73%)
Log in

OTCMKTS:MDCL - Medicine Man Technologies Stock Price, Forecast & News

$2.00
-0.30 (-13.04 %)
(As of 02/27/2020 04:00 PM ET)
Today's Range
$2.00
Now: $2.00
$2.32
50-Day Range
$2.00
MA: $2.53
$3.00
52-Week Range
$1.85
Now: $2.00
$4.17
Volume167,278 shs
Average Volume80,326 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Medicine Man Technologies, Inc. provides cultivation consulting services for cannabis growing technologies and methodologies. The company also provides licensing and seminar services. In addition, it engages in retail operations of cannabis products. The company was founded in 2014 and is based in Denver, Colorado.

Industry, Sector and Symbol

Industry Business Services
Sub-IndustryCannabis
SectorIndustrials
Current SymbolOTCMKTS:MDCL
Previous SymbolNASDAQ:MDCL
CUSIPN/A
Phone+1-303-3710387

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees25
Next Earnings DateN/A
OptionableNot Optionable

Receive MDCL News and Ratings via Email

Sign-up to receive the latest news and ratings for MDCL and its competitors with MarketBeat's FREE daily newsletter.


Medicine Man Technologies (OTCMKTS:MDCL) Frequently Asked Questions

What is Medicine Man Technologies' stock symbol?

Medicine Man Technologies trades on the OTCMKTS under the ticker symbol "MDCL."

Has Medicine Man Technologies been receiving favorable news coverage?

Media headlines about MDCL stock have trended extremely negative this week, according to InfoTrie Sentiment. The research firm identifies negative and positive press coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Medicine Man Technologies earned a media sentiment score of -4.2 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the company's share price in the immediate future. View News Stories for Medicine Man Technologies.

Who are some of Medicine Man Technologies' key competitors?

What other stocks do shareholders of Medicine Man Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Medicine Man Technologies investors own include Canopy Growth (CGC), Curaleaf (CURLF), Aurora Cannabis (ACB), Innovative Industrial Properties (IIPR), Cronos Group (CRON), Charlotte's Web (CWBHF), KushCo (KSHB), OrganiGram (OGI), Trulieve Cannabis (TCNNF) and CV Sciences (CVSI).

Who are Medicine Man Technologies' key executives?

Medicine Man Technologies' management team includes the folowing people:
  • Mr. Paul D. Dickman, Chairman, Corp. Sec. & Interim CFO (Age 39)
  • Mr. Andrew Williams, Co-Founder, Director & CEO (Age 50)
  • Mr. Joshua Haupt, Chief Revenue Officer (Age 32)
  • Mr. Joseph P. Puglise, COO & Director (Age 49)
  • Mr. James S. Toreson, Consultant (Age 77)

How do I buy shares of Medicine Man Technologies?

Shares of MDCL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Medicine Man Technologies' stock price today?

One share of MDCL stock can currently be purchased for approximately $2.00.

What is Medicine Man Technologies' official website?

The official website for Medicine Man Technologies is http://medicinemantechnologies.com/.

How can I contact Medicine Man Technologies?

Medicine Man Technologies' mailing address is 4880 Havana St, DENVER, CO 80239-2402, United States. The company can be reached via phone at +1-303-3710387.


MarketBeat Community Rating for Medicine Man Technologies (OTCMKTS MDCL)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  102 (Vote Outperform)
Underperform Votes:  87 (Vote Underperform)
Total Votes:  189
MarketBeat's community ratings are surveys of what our community members think about Medicine Man Technologies and other stocks. Vote "Outperform" if you believe MDCL will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MDCL will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/27/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel